Neuroendocrine and Immune Responses in Humans During and After Long Term Stay at ISS (Immuno) provides an understanding for the development of pharmacological tools to counter unwanted immunological side-effects during long-duration missions in space.Principal Investigator(s)
German Aerospace Center (DLR), Cologne, , Germany
European Space Agency (ESA)Sponsoring Organization
Information PendingResearch Benefits
Information PendingISS Expedition Duration:
October 2005 - September 2013Expeditions Assigned
12,13,14,15,16,27/28,29/30,31/32,33/34,35/36Previous ISS Missions
Immuno began collecting samples from subjects during Increment 14.
Immuno will determine neuroendocrine and immunological changes during and after working and living on the ISS. A focus on cellular energy metabolism and cell signaling will provide additional information on the psycho-neuroendocrine and immunologic adaptation of human physiology to space and a better insight on how these processes are dependent on the cellular level of signal processing.
Immuno aims to provide the understanding for the development of pharmacological tools to countermeasure unwanted immunological side effects during long-duration missions into space.Earth Applications
The Immuno investigation will provide insight into the disease process of immunocompromised humans on Earth.
Immuno will involve taking several preflight and inflight measurements. A Current Stress Test (CST), paper stress test designed to repeatedly determine an individuals' psychological state under the conditions of acute and chronic stress, is taken. A urine collection will be performed for determination of dopamine or epinephrine in urine collected within 24 hours. A saliva collection will be performed in the morning and in the evening by chewing on a cotton swab for 30-45 seconds. Fluid will then be removed from the swab by centrifugation and kept frozen at -20 degrees C. Blood collections will also be performed to analyze the blood and blood components. This experiment is planned to be carried out over multiple ISS Increment crews, requiring six subjects in total.Operational Protocols
A preflight test will be conducted between launch minus 30 days (L-30) and launch minus 7 days (L-7). Two inflight sample collections will occur; the first between launch plus 30 days (L+30) and launch plus 90 days (L+90). The second inflight sample collection will occur between launch plus 150 days (L+150) and return minus 14 days (R-14).
Thirty (30) cosmonauts on short-duration (8?11 days) and long-duration (125?195 days) missions to ISS were studied before launch and after landing in order to detect changes in the immune system which had been reported in previous studies with short- and long-duration space missions in low Earth orbit (LEO).
In 2008, Rykova et al. published the first results on the Humoral Immune Response (HIR) of ISS cosmonauts. The HIR study focused on peripheral blood antibodies, T- and B-lymphocyte white blood cell (WBC) populations, cytokines (cell-signaling agents), as well as natural killer (NK) cells activity in the body?s defense against bacteria, viruses, and toxins.
No notable changes in the antiviral antibody levels after long- and short-term missions were observed, and specific antibodies for Epstein-Barr viruses (EBVs), which were often reactivated in microgravity, also did not change. Although the total number of WBCs increased significantly upon landing, the overall population of T and B lymphocytes did not change appreciably after long-duration space flights. However, T-lymphocyte function was decreased which supports previous observations and recently confirmed by Morukov et al. from a study of 12 Russian cosmonauts after long-duration missions. Researchers proposed that a long-duration space flight, perhaps coupled with several extravehicular activities (EVA), activated and suppressed T-lymphocytes? response to proliferate, thus resulted in an immune deficit against potential infections. The investigation also showed gross individual differences in concentration of cytokines before launch due possibly to preflight stress. The random changes after short- and long-term missions suggest that cytokines may be highly sensitivity to the factors associated with reentry and readaptation to Earth?s gravity. Also, a decrease in natural killer (NK) cells population and activity in the long-duration crewmembers may be an indication of a weakened immune system, plus the reduced NK activity in some subjects on the first day after short-duration could very well be an acute response to landing stress.
Many improvements have been made to the living conditions of orbital vehicles and the scope of space flight immunological research expanded since the first human was flown into space 50 years ago. However, ISS crewmembers still exhibit negative shifts in the immune system during initial readaptation to gravity. Such alterations, scientists suspect, could lead to compromised defenses against infections by limiting the immune system?s communicating and disease fighting capabilities. In light of these results, full characterization of all aspects of the innate and adaptive immune system after prolonged and brief flights appears essential for understanding the relationship of microgravity and stress effects of space flight on human space explorers (Rykova et al. 2008, Morukov et al. 2011).
Morukov BV, Rykova MP, Antropova EN, Berendeeva T, Ponomaryov S, Larina IM. T-cell immunity and cytokine production in cosmonauts after long-duration space flights. Acta Astronautica. 2011; 68: 739-746. DOI: 10.1016/j.actaastro.2010.08.036.
Rykova MP, Antropova EN, Larina IM, Morukov BV. Humoral and cellular immunity in cosmonauts after the ISS mission. Acta Astronautica. 2008; 63: 697-705. DOI: 10.1016/j.actaastro.2008.03.016.
Chouker A, Demetz F, Martignoni A, Smith L, Setzer F, Bauer A, Hölzl J, Peter K, Christ F, Thiel M. Strenuous physical exercise inhibits granulocyte activation induced by high altitude. Journal of Applied Physiology. 2005; 98(2): 640-647. DOI: 10.1152/japplphysiol.00036.2004..